文献速递淋巴瘤

B细胞表达cFLIP对弥漫性大B细胞淋巴瘤发病至关重要

Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis.
PubMed 文献 · Blood · 2026-01-01

该研究在自发小鼠模型中证实,B细胞表达cFLIP是MYD88致癌信号联合BCL2过表达驱动DLBCL发生所必需的;在人类ABC-DLBCL(非GCB亚型)细胞中,cFLIP缺失可致其对TRAIL或LPS诱导的caspase-8依赖性凋亡敏感,并发现cFLIP在ABC亚型中具有转录水平抑制促炎细胞因子的非细胞死亡依赖性作用。

要点

  • B细胞特异性敲除Cflar可阻止MYD88联合BCL2过表达介导的淋巴瘤发生。
  • cFLIP缺失使ABC-DLBCL(非GCB)对TRAIL或LPS诱导的caspase-8依赖性凋亡敏感。
  • cFLIP在ABC亚型中具有转录抑制促炎细胞因子的非细胞死亡依赖性功能。

核心结论

  • B细胞表达cFLIP是DLBCL发病所必需的,且内在凋亡抑制只有在外部凋亡受控时才能促进淋巴瘤发生。

研究设计与样本

  • 采用自发小鼠模型,通过B细胞特异性删除Cflar基因研究cFLIP在MYD88致癌信号联合BCL2过表达驱动DLBCL发生中的作用。
  • 在人类淋巴瘤细胞中比较ABC-DLBCL与GCB-DLBCL亚型对cFLIP缺失的凋亡敏感性。

主要发现

  • B细胞特异性删除Cflar阻止了致癌Myd88联合BCL2过表达介导的淋巴瘤发生。
  • cFLIP缺失使ABC-DLBCL而非GCB-DLBCL细胞对TRAIL或脂多糖诱导的caspase-8介导凋亡敏感。
  • cFLIP在ABC亚型中选择性通过转录水平抑制促炎细胞因子,且该作用不依赖细胞死亡。

临床怎么用

  • 为开发cFLIP抑制剂治疗ABC-DLBCL及可能其他血液肿瘤提供依据。
  • 通过CFLAR缺失激活外部凋亡通路可在内在凋亡受抑制的DLBCL细胞中有效促死亡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous malignant disease that remains a major clinical challenge, as relapsed and refractory disease is difficult to treat. Apoptosis evasion is a major feature of DLBCL. However, while the suppression of intrinsic apoptosis has long been recognized as a lymphoma-promoting event, the role of extrinsic apoptosis has remained poorly defined. In this study, we demonstrated at the genetic level that expression of cellular Fas-associated death domain protein-like IL-1β-converting enzyme-inhibitory protein (cFLIP), the most crucial, non-redundant inhibitor of extrinsic apoptosis, in B cells is necessary for the development of DLBCL in an autochthonous murine model. Indeed, B-cell-specific deletion of Cflar, the gene encoding for cFLIP, prevented lymphomagenesis mediated by oncogenic Myd88 and overexpression of BCL2. In human lymphoma cells, we showed that the absence of cFLIP sensitized activated B-cell-like (ABC)- but not germinal center B-cell-like (GCB)-DLBCL subtype cells to TRAIL- or lipopolysaccharide-induced, caspase-8-mediated apoptosis. Furthermore, we unveiled a cell death-independent role of cFLIP in the suppression of proinflammatory cytokines at the transcriptional level, selectively in the ABC subtype. These results indicate that the suppression of intrinsic apoptosis can support lymphomagenesis only if extrinsic apoptosis is properly controlled. Moreover, licensing extrinsic apoptosis through CFLAR deletion can efficiently promote death in DLBCL cells, despite the suppression of the intrinsic pathway. Overall, these data provide a rationale for the development of cFLIP inhibitors for the treatment of ABC-DLBCL and possibly other hematological cancers.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Bariboloka KT, Serrano-Saenz S, Savcigil DP, et al. Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis. Blood. 2026. PMID: 42024475. doi:10.1182/blood.2026033320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。